The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public ...

The FDA published a database of letters sent to drugmakers during the review process of medications that provide information on the agency's initial feedback or requirements for more data. These ...

The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as ...